CHCTMEDIUM SIGNALFINANCIAL10-K

CHCT's interest expense increased substantially while the company reduced its property portfolio from 200 to 198 properties and expanded its weighted average lease term.

The significant increase in interest expense suggests higher borrowing costs or increased debt levels, which could pressure profit margins and cash flows. The portfolio consolidation through property disposals appears strategic, as the company maintained similar total square footage while extending average lease terms to 7.0 years, indicating a focus on higher-quality, longer-duration assets.

Comparing 2026-02-17 vs 2025-02-18View on EDGAR →
FINANCIAL ANALYSIS

Interest expense increased substantially to $17.8 million, representing a notable jump in financing costs that will impact profitability. Cash and equivalents declined modestly to $3.3 million, reflecting a tighter liquidity position. The overall financial picture suggests CHCT is managing through a higher interest rate environment while maintaining operational stability through portfolio optimization.

FINANCIAL STATEMENT CHANGES
Interest Expense
P&L
+49.9%
$11.9M→$17.8M

Interest expense surged 49.9% — significant debt increase or rising rates materially impacting earnings.

Cash & Equivalents
Balance Sheet
-23.8%
$4.4M→$3.3M

Cash decreased 23.8% — monitor burn rate and upcoming capital needs.

LANGUAGE CHANGES
NEW — 2026-02-17
PRIOR — 2025-02-18
ADDED
on June 30, 2025) of the Registrant held by non-affiliates (for purposes of this calculation, all of the Registrant's directors and executive officers are deemed affiliates of the Registrant) on June 30, 2025 was approximately $ 448.8 million .
The Registrant had 28,571,793 shares of co mmon stock, $0.01 par value per share, outstanding as of February 10, 2026.
Real Estate Investments As of December 31, 2025, we had gross investments of approximately $1.2 billion in 198 real estate properties (including one property, with sales-type leases, with a gross amount totaling approximately $8.1 million and one property classified as held for sale with a net investment totaling approximately $5.3 million).
The properties are located in 36 states, totaling approximately 4.5 million square feet in the aggregate, with a weighted average remaining lease term of approximately 7.0 years.
Excluding the real estate asset held for sale at December 31, 2025, the properties were approximately 90.6% leased.
+7 more — sign up free →
REMOVED
on June 30, 2024) of the Registrant held by non-affiliates (for purposes of this calculation, all of the Registrant's directors and executive officers are deemed affiliates of the Registrant) on June 30, 2024 was approximately $ 628.0 million .
The Registrant had 28,339,419 shares of co mmon stock, $0.01 par value per share, outstanding as of February 11, 2025.
Real Estate Investments As of December 31, 2024, we had gross investments of approximately $1.2 billion in 200 real estate properties (including a portion of one property accounted for as a sales-type lease with a gross amount totaling approximately $3.0 million and two properties classified as held for sale with an aggregate amount totaling approximately $6.8 million).
The properties are located in 36 states, totaling approximately 4.4 million square feet in the aggregate and were approximately 90.9% leased, excluding real estate assets held for sale, at December 31, 2024 with a weighted average remaining lease term of approximately 6.7 years.
Number of Properties Annualized Rent (%) Medical Office Building (MOB) 93 36.9 % Inpatient Rehabilitation Facilities (IRF) 9 19.2 % Acute Inpatient Behavioral (AIB) 5 13.0 % Specialty Centers (SC) 37 10.3 % Physician Clinics (PC) 35 8.3 % Behavioral Specialty Facilities (BSF) 12 6.2 % Surgical Centers and Hospitals (SCH) 7 4.0 % Long-term Acute Care Hospitals (LTACH) 2 2.1 % Total real estate investments 200 100.0 % Customer Concentrations The Company's real estate portfolio is leased to a diverse tenant base.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →